factual
In Vivo CAR-T Offers Dramatic Tumor Reduction
Next-generation CAR T approaches, including in vivo methods such as those from Capstan, show potential to reduce tumors by 100 percent in more than 70 percent of patients and keep them controlled for long periods.
factualpending
Speaker
AlexEvidence Quote
“they have the potential to reduce tumors by 100 percent and to do that in 70 percent plus of patients”
Source
Alex Karnal - The Trillion-Dollar Health Revolution - [Invest Like the Best, EP.468]— Invest Like the BestCreated: 11/14/2026, 4:24:39 AM
Your notes
Loading notes...